We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
-9.7%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$1.22B
AUM Growth
-$882M
Cap. Flow
-$698M
Cap. Flow %
-57.3%
Top 10 Hldgs %
37.48%
Holding
87
New
26
Increased
14
Reduced
19
Closed
26

Top Buys

Rank Stock Value
1
MCK icon
McKesson
MCK
+$50.4M
2
ABBV icon
AbbVie
ABBV
+$47.5M
3
HRTX icon
Heron Therapeutics
HRTX
+$46.7M
4
CAH icon
Cardinal Health
CAH
+$45.6M
5
BDX icon
Becton Dickinson
BDX
+$38.3M

Top Sells

Rank Stock Value
1
BOLD
Audentes Therapeutics, Inc
BOLD
+$73.8M
2
NVRO
NEVRO CORP.
NVRO
+$67.8M
3
ZBH icon
Zimmer Biomet
ZBH
+$66.3M
4
GILD icon
Gilead Sciences
GILD
+$55.2M
5
AGN
Allergan plc
AGN
+$53.8M

Sector Composition

Rank Sector Weight
1 Healthcare 84.43%
2 Technology 3.14%
3 Consumer Discretionary 1.97%
4 Industrials 0.46%
5 Utilities 0.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XYZ
76
Block Inc
XYZ
$47.5B
– –
-80,427
Closed -$5.03M
NVRO
77
DELISTED
NEVRO CORP.
NVRO
– –
-577,163
Closed -$67.8M
CTLT
78
DELISTED
CATALENT, INC.
CTLT
– –
-316,962
Closed -$17.8M
AXNX
79
DELISTED
Axonics, Inc. Common Stock
AXNX
– –
-550,026
Closed -$15.2M
CSII
80
DELISTED
Cardiovascular Systems, Inc.
CSII
– –
-274,689
Closed -$13.3M
AGN
81
DELISTED
Allergan plc
AGN
– –
-281,548
Closed -$53.8M
DERM
82
DELISTED
Dermira, Inc.
DERM
– –
-2,271,180
Closed -$34.4M
BOLD
83
DELISTED
Audentes Therapeutics, Inc
BOLD
– –
-1,232,873
Closed -$73.8M
ELGX
84
DELISTED
Endologix Inc
ELGX
– –
-159,285
Closed -$252K
1 2 3
4

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return
YL
YCG LLC Austin, Texas $1.1B AUM 4.87% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
PWA
Pitcairn Wealth Advisors Conshohocken, Pennsylvania $1.09B AUM

PFM Health Sciences's Q1 2020 Portfolio in Review

As of Q1 2020, PFM Health Sciences held 87 positions worth $1.22B, down 42% from $2.1B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

PFM Health Sciences withdrew a net $698M in Q1 2020, closing 26 positions and reducing 19 holdings. Its most notable exit was Audentes Therapeutics, Inc, an estimated $73.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 70% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PFM Health Sciences opened a new position in McKesson worth $46.5M.

  • PFM Health Sciences's largest Q1 2020 buy was McKesson: 343,950 shares worth $46.5M.
  • PFM Health Sciences added most to AbbVie in Q1 2020, an estimated $47.5M increase.
  • PFM Health Sciences's biggest Q1 2020 reduction was Gilead Sciences, cutting an estimated $55.2M.
  • PFM Health Sciences fully exited Audentes Therapeutics, Inc in Q1 2020, selling an estimated $73.8M.
  • PFM Health Sciences's ten largest holdings make up 37% of its $1.22B portfolio in Q1 2020.
  • PFM Health Sciences opened 26 new positions and closed 26 in Q1 2020.
  • PFM Health Sciences's portfolio value fell 42% quarter-over-quarter to $1.22B.

Based on PFM Health Sciences's 13F filing for Q1 2020, filed 15 May 2020.